SEVERITY OF ANXIETY AND SYMPTOMS OF DYSFUNCTIONAL BREATHING IN PATIENTS WITH CHRONIC RESPIRATORY DISEASES IN THE COVID-19 PANDEMIC
Introduction The conditions of the COVID-19 pandemic, as well as the risks associated with it, led to a deterioration in the emotional state of many people: during the pandemic, an increase in the frequency of anxiety disorders was noted, especially among patients with chronic diseases of the respi...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2023-03-01
|
| Series: | European Psychiatry |
| Online Access: | https://www.cambridge.org/core/product/identifier/S0924933823016644/type/journal_article |
| _version_ | 1797617419516116992 |
|---|---|
| author | E. R. Semenova E. Pervichko D. Shulga I. Shishkova |
| author_facet | E. R. Semenova E. Pervichko D. Shulga I. Shishkova |
| author_sort | E. R. Semenova |
| collection | DOAJ |
| description |
Introduction
The conditions of the COVID-19 pandemic, as well as the risks associated with it, led to a deterioration in the emotional state of many people: during the pandemic, an increase in the frequency of anxiety disorders was noted, especially among patients with chronic diseases of the respiratory system. Since the beginning of the COVID-19 pandemic, the respiratory system has been described as very “vulnerable” to the coronavirus.
Objectives
To study the severity of anxiety and symptoms of dysfunctional breathing (DB) in patients with chronic respiratory diseases in the conditions of the COVID-19 pandemic.
Methods
We used: «The Perceived Stress Scale-10», «State-Trait Anxiety Inventory», «Short Health Anxiety Inventory», and Nijmegen questionnaire.The sample: 89 patients with respiratory diseases, the average age was 49.21±18.3. Of these, 38 patients with upper respiratory tract diseases (URTD) (J30-J39) and 51 patients with lower respiratory tract diseases (LRTD) (J40-J47). 49 people had a history of COVID-19 disease.
Results
The sample of patients with both URTD and LRTD diseases is characterized by a high level of stress (27.13±6.937 vs 28.59±6.014, p=0.293). The average indicators of health anxiety in patients with LRTD diseases significantly exceed those of patients with URTD diseases (20.18±8.881 vs 15.68±7.022; p=0.01), which is consistent with data on a greater assessment of the disease threat compared with patients with upper respiratory tract diseases.The severity of DB symptoms in the group of patients with LRTD diseases significantly exceeds that in the group of patients with URTD (19.05±12.340 vs 24.29±11.470; p=0.042). Also in this group, there is a greater severity of individual symptoms of DB: spasm of the mouth muscles (p= 0.015), accelerated deep breathing (p= 0.002), shallow breathing (p=0.001) and the inability to take a deep breath (p=0.001).When analyzing the symptoms among patients who had and did not have a history of COVID-19, significant differences were found in such manifestations of DB as dizziness (1.98±1.351 vs 1.27±1.232; p=0.024) and confusion in the environment (0.61±0.891 vs 0.18±0.465; p=0.010), and also according to the severity of the symptoms of DB in general (23.76±11.996 vs 17.81±8.461; t=2.007, p=0.043).During the analysis, a relationship was established between the severity of DB symptoms and alertness to bodily sensations (R=0.259, p=0.014), which may indicate both an increase in DB symptoms with increased attention toward sensory sensations, and greater screening activity with an increase in DB symptoms. Increased alertness to bodily sensations is associated with situational stress (R=0.530; p=0.001) and personal anxiety (R=0.495, p=0.001).
Conclusions
The results obtained make it possible to identify categories of patients with chronic respiratory diseases who need psychological counseling and psychotherapy.
Disclosure of Interest
None Declared |
| first_indexed | 2024-03-11T07:55:45Z |
| format | Article |
| id | doaj.art-718a021641fd41449f39d11f89b2f9c5 |
| institution | Directory Open Access Journal |
| issn | 0924-9338 1778-3585 |
| language | English |
| last_indexed | 2024-03-11T07:55:45Z |
| publishDate | 2023-03-01 |
| publisher | Cambridge University Press |
| record_format | Article |
| series | European Psychiatry |
| spelling | doaj.art-718a021641fd41449f39d11f89b2f9c52023-11-17T05:05:52ZengCambridge University PressEuropean Psychiatry0924-93381778-35852023-03-0166S788S78810.1192/j.eurpsy.2023.1664SEVERITY OF ANXIETY AND SYMPTOMS OF DYSFUNCTIONAL BREATHING IN PATIENTS WITH CHRONIC RESPIRATORY DISEASES IN THE COVID-19 PANDEMICE. R. Semenova0E. Pervichko1D. Shulga2I. Shishkova3Moscow State University named after ‘M. V. Lomonosov’, MoscowMoscow State University named after ‘M. V. Lomonosov’, MoscowMoscow State University named after ‘M. V. Lomonosov’, MoscowRyazan State Medical University, Ryazan, Russian Federation Introduction The conditions of the COVID-19 pandemic, as well as the risks associated with it, led to a deterioration in the emotional state of many people: during the pandemic, an increase in the frequency of anxiety disorders was noted, especially among patients with chronic diseases of the respiratory system. Since the beginning of the COVID-19 pandemic, the respiratory system has been described as very “vulnerable” to the coronavirus. Objectives To study the severity of anxiety and symptoms of dysfunctional breathing (DB) in patients with chronic respiratory diseases in the conditions of the COVID-19 pandemic. Methods We used: «The Perceived Stress Scale-10», «State-Trait Anxiety Inventory», «Short Health Anxiety Inventory», and Nijmegen questionnaire.The sample: 89 patients with respiratory diseases, the average age was 49.21±18.3. Of these, 38 patients with upper respiratory tract diseases (URTD) (J30-J39) and 51 patients with lower respiratory tract diseases (LRTD) (J40-J47). 49 people had a history of COVID-19 disease. Results The sample of patients with both URTD and LRTD diseases is characterized by a high level of stress (27.13±6.937 vs 28.59±6.014, p=0.293). The average indicators of health anxiety in patients with LRTD diseases significantly exceed those of patients with URTD diseases (20.18±8.881 vs 15.68±7.022; p=0.01), which is consistent with data on a greater assessment of the disease threat compared with patients with upper respiratory tract diseases.The severity of DB symptoms in the group of patients with LRTD diseases significantly exceeds that in the group of patients with URTD (19.05±12.340 vs 24.29±11.470; p=0.042). Also in this group, there is a greater severity of individual symptoms of DB: spasm of the mouth muscles (p= 0.015), accelerated deep breathing (p= 0.002), shallow breathing (p=0.001) and the inability to take a deep breath (p=0.001).When analyzing the symptoms among patients who had and did not have a history of COVID-19, significant differences were found in such manifestations of DB as dizziness (1.98±1.351 vs 1.27±1.232; p=0.024) and confusion in the environment (0.61±0.891 vs 0.18±0.465; p=0.010), and also according to the severity of the symptoms of DB in general (23.76±11.996 vs 17.81±8.461; t=2.007, p=0.043).During the analysis, a relationship was established between the severity of DB symptoms and alertness to bodily sensations (R=0.259, p=0.014), which may indicate both an increase in DB symptoms with increased attention toward sensory sensations, and greater screening activity with an increase in DB symptoms. Increased alertness to bodily sensations is associated with situational stress (R=0.530; p=0.001) and personal anxiety (R=0.495, p=0.001). Conclusions The results obtained make it possible to identify categories of patients with chronic respiratory diseases who need psychological counseling and psychotherapy. Disclosure of Interest None Declaredhttps://www.cambridge.org/core/product/identifier/S0924933823016644/type/journal_article |
| spellingShingle | E. R. Semenova E. Pervichko D. Shulga I. Shishkova SEVERITY OF ANXIETY AND SYMPTOMS OF DYSFUNCTIONAL BREATHING IN PATIENTS WITH CHRONIC RESPIRATORY DISEASES IN THE COVID-19 PANDEMIC European Psychiatry |
| title | SEVERITY OF ANXIETY AND SYMPTOMS OF DYSFUNCTIONAL BREATHING IN PATIENTS WITH CHRONIC RESPIRATORY DISEASES IN THE COVID-19 PANDEMIC |
| title_full | SEVERITY OF ANXIETY AND SYMPTOMS OF DYSFUNCTIONAL BREATHING IN PATIENTS WITH CHRONIC RESPIRATORY DISEASES IN THE COVID-19 PANDEMIC |
| title_fullStr | SEVERITY OF ANXIETY AND SYMPTOMS OF DYSFUNCTIONAL BREATHING IN PATIENTS WITH CHRONIC RESPIRATORY DISEASES IN THE COVID-19 PANDEMIC |
| title_full_unstemmed | SEVERITY OF ANXIETY AND SYMPTOMS OF DYSFUNCTIONAL BREATHING IN PATIENTS WITH CHRONIC RESPIRATORY DISEASES IN THE COVID-19 PANDEMIC |
| title_short | SEVERITY OF ANXIETY AND SYMPTOMS OF DYSFUNCTIONAL BREATHING IN PATIENTS WITH CHRONIC RESPIRATORY DISEASES IN THE COVID-19 PANDEMIC |
| title_sort | severity of anxiety and symptoms of dysfunctional breathing in patients with chronic respiratory diseases in the covid 19 pandemic |
| url | https://www.cambridge.org/core/product/identifier/S0924933823016644/type/journal_article |
| work_keys_str_mv | AT ersemenova severityofanxietyandsymptomsofdysfunctionalbreathinginpatientswithchronicrespiratorydiseasesinthecovid19pandemic AT epervichko severityofanxietyandsymptomsofdysfunctionalbreathinginpatientswithchronicrespiratorydiseasesinthecovid19pandemic AT dshulga severityofanxietyandsymptomsofdysfunctionalbreathinginpatientswithchronicrespiratorydiseasesinthecovid19pandemic AT ishishkova severityofanxietyandsymptomsofdysfunctionalbreathinginpatientswithchronicrespiratorydiseasesinthecovid19pandemic |